Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 10:45 PM
Ignite Modification Date: 2025-12-24 @ 10:45 PM
NCT ID: NCT01751035
Eligibility Criteria: Inclusion Criteria: * 1\) 13-18 years old; * 2\) Presenting to LCC/HH for evaluation or treatment; * 3\) Report having experienced IPV in their lifetime, including: CSA, defined as forced or unwanted: (a) vaginal or anal penetration by an object, finger, or penis; (b) oral sex; (c) touching of the respondent's breasts or genitalia; or (d) respondents' touching of another person's genitalia; CPA, defined as having been (a) attacked or threatened with a gun, knife, or some other weapon; (b) attacked by another person with perceived intent to kill or seriously injure; (c) beaten and injured (i.e., "hurt pretty badly") by another person; (d) spanked so forcefully that it resulted in sustained welts or bruises or required medical care; or (e) cut, burned, or tied up by a caregiver as a punitive consequence; Exposure to Domestic Violence; and being victim of or bearing witness to Community Violence. * 4\) Have a memory of the incident(s); * 5\) Five or more DSM-IV PTSD symptoms; * 6\) Substance use, defined as alcohol or illicit drug use in the past 90 days per self-report and/or urine drug screen or breathalyzer. Exclusion Criteria: * 1\) Previously identified as having a Pervasive Developmental Disability or Moderate to Severe Mental Retardation; * 2\) Actively suicidal or homicidal; * 3\) Reports active psychotic disorder
Healthy Volunteers: False
Sex: ALL
Minimum Age: 13 Years
Maximum Age: 18 Years
Study: NCT01751035
Study Brief:
Protocol Section: NCT01751035